Based on the mechanism of autoimmune disease and antibodies, invasive skeletal muscle molecules, thymus status, genetic characteristics, disease phenotype and response to treatment, myasthenia gravis is divided into early and late ocular subtypes (OMG), seronegative, thymoma, LRP4, MuSk. The gene discussed is LRP4; the disease is myasthenia gravis.